🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Analysis of HCV-specific T cell responses in patients treated with boceprev...
Status
Completed
Location
Unit of Infectious Diseases and Hepatology
Start Date
2012-04
Trial ID
NCT01403181
Treatments Being Tested
1. To characterize the tolerability profile of subcutaneous (SC) CPG 10101 ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00142103
The results of antiviral therapy in patients with recurrent hepatitis C aft...
Status
Completed
Location
Sapienza University of Rome
Start Date
2009-10
Trial ID
NCT00993122
Treatments Being Tested
This study is divided into 2 segments, and proposes to qualify fine needle ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01547312
The objective is to evaluate the efficacy and safety of the combination the...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00686777
Treatments Being Tested
This study will assess the efficacy of boceprevir (BOC) in combination with...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-21
Trial ID
NCT01390844
This study aims to compare the role of peginterferon α-2b (50 μg/week) vs. ...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00759109
Treatments Being Tested
This study will evaluate the efficacy and safety of MP-424 with Peginterfer...
Status
Completed
Location
Toranomon Hospital
Start Date
2008-11
Trial ID
NCT00780416
Treatments Being Tested
This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-18
Trial ID
NCT00237484
The objective of the study is to select an optimal dose of taribavirin by c...
Status
Completed
Location
Cedars-Sinai Medical Center, 8635 W. 3rd Street, Suite 590W
Start Date
2007-03
Trial ID
NCT00446134
Treatments Being Tested